Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001104659-26-038057

Director sold 7,000,000 shares at $34.66 ($242,620,000)

  • Director acquired 7,000,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Fairmount Funds Management LLC · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-31 Conversion : show line 1 in the form +7,000,000 12,503,418 I
2026-03-31 Sale : show line 2 in the form −7,000,000 $34.66 $242,620,000 5,503,418 I
Open-market sales · 7,000,000 sh · avg $34.66 · $242,620,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-31 Conversion : show line 3 in the form Series A Convertible Preferred Stock −28,000 39,414 I
Loading xslF345X06/tm2610819-2_4seq1.xml…